The Bloom 154 - Integrating Clinical Psychedelic Research


The Bloom #154

Free Edition

ketacol

I'm excited to share some updates alongside the latest psychedelic research articles. We've just completed a significant update to our trials database, now featuring 900 psychedelic trials sourced from ClinicalTrials.gov, national databases, company announcements, and more.

Floris - Founder of Blossom

ps My friend Henry writes the twice-weekly Tricycle Day newsletter with much more news on psychedelics, I highly recommend checking it out.

1 Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems

This double-blind, pilot study (n=28) investigates esketamine combined with mindfulness-based intervention (MBI) for individuals with alcohol misuse problems. Esketamine enhanced psychological engagement in MBI and transiently decreased alcohol cravings, while also resulting in greater mystical experiences and dissociative states compared to placebo.

Also, see this study from last week, which found no lasting effects (in a small population) of psychedelics on alcohol use: Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial

Unlock 2100+ Psychedelic Research Summaries with a Pro Membership

Discover a treasure trove of knowledge and support the vital coverage & advancement of psychedelic research

2 The Role of Music in Psychedelic-Assisted Therapy: A Comparative Analysis of Neuroscientific Research, Indigenous Entheogenic Ritual, and Contemporary Care Models

This review evaluates the role of music in psychedelic-assisted therapies (PAT) and indigenous entheogenic ceremonies. It examines neuroscientific, psychological, and anthropological research, highlighting the need for personalized music protocols and the integration of traditional practices into modern treatment models to enhance clinical outcomes.

3 Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement

This consensus statement (n=27) identifies key ethics and policy issues for integrating psychedelic therapies into clinical practice. It reports 20 points of consensus across 5 ethical issues, with relevant actors responsible for implementation, and highlights areas needing further research and deliberation.

More new research

New on Blossom

1 Psychedelic Research Recap May

Psychedelic research in May 2024 investigates awe in ketamine therapy, role of therapy in PAT, touch guidelines, and more.

Gain Unparalleled Insight with Pro
Access 2100+ Research Summaries

"Blossom provides an invaluable insight into the fast-moving world of psychedelic research" - Clara Burtenshaw

2 Psychedelic Research Links 2024

All the other papers that have come out this year that don't have a separate entry in the database.

Spotlight

No spotlight this week.

Molenvaart 76, Anna Paulowna, NH 1761AL
Unsubscribe · Preferences

Floris from Blossom

I write about the science and implementation of psychedelics as medicines. Join to learn alongside me and make the future happen sooner!

Read more from Floris from Blossom

The Bloom #182 Free Edition Europe awakens Between May and June, the number of research articles we've added to the database shot up by 80%. Ok, that is going from 10 to 18, but still, a lot of valuable research is hot off the press. You can read the full recap of June's research on Blossom. This month, more research has been published on the mystical experience, OCD, and psilocybin-assisted therapy for bipolar II. Looking forwards, many conferences are happening all around Europe. Here are a...

The Bloom #180 Free Edition integrate this Since the last newsletter, psychedelic research has made a 180-degree turn. Where before the research was a bit slow, the end of June proved to be fertile ground for the study of psychedelics. Instead of the three most interesting articles, see six featured below. In total, 18 new publications were added to the database in the past few weeks. We cover the first PET-MRI study of LSD, the first study of vaporised DMT, a long-term follow-up of...

The Bloom #180 Free Edition the science is my passion It is with great sadness and profound gratitude that I want to acknowledge the passing of psychedelic pioneer Amanda Fielding on May 22nd. As the driving force behind the psychedelic research renaissance, her visionary work has left an indelible mark on the field, and she will be dearly missed. See her obituary in The Economist here. Last month's research was relatively slow, and I've recapped it here. Floris - Founder of Blossom ps...